Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

The Nippon Synthetic Chemical Industry

大正製薬ホールディングス

中外製薬

持田製薬

Takeda Pharmaceutical

Mitsubishi Tanabe Pharma

Sekisui Chemical

ADEKA

Shin-Etsu Chemical

ROHTO PHARMACEUTICAL

Nihon Parkrizing

HISAMITSU PHARMACEUTICAL

NIPPON PAINT

エスケー化研

キッセイ薬品工業

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

Yushiro Chemical Indutry

メルコホールディングス

Renesas Electronics

NITCHITSU　

日本アビオニクス

Financial Indicator Details: SSP (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: SSP (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-12-31
Net profit margin (Industry Average)	3.77% (3.05%)
C/F margin (Industry Average)	6.43% (8.25%)
ROA (Industry Average)	2.57% (2.71%)
ROE (Industry Average)	3.11% (4.57%)
Growth	2009-12-31
Equity growth (Industry Average)	- (8.16%)
Sales growth (Industry Average)	- (-)
Net profit growth (Industry Average)	- (90.38%)
Operating C/F growth (Industry Average)	- (138.39%)
Stability	2009-12-31
Capital adequacy (Industry Average)	82.73% (56.30%)
Liquidity ratio (Industry Average)	398.85% (236.21%)
C/F ratio current liabilities (Industry Average)	372.11% (573.30%)
Quick ratio (Industry Average)	227.67% (156.81%)
Turnover	2009-12-31
Receivables turnover (Industry Average)	98.62day (98.27day)
Inventory turnover (Industry Average)	34.42day (58.68day)
Payable turnover (Industry Average)	22.37day (51.12day)
Working capita turnover (Industry Average)	110.67day (105.83day)
Stock etc.	2009-12-31
Market Value growth (Industry Average)	- (21.16%)
Dividend Yield (Industry Average)	- (2.07%)
PER (Industry Average)	- (16.58%)
PBR (Industry Average)	- (1.08%)
PCFR (Industry Average)	- (7.56%)
PSR (Industry Average)	- (1.01%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-12-31
Net profit margin (Industry Average)	3.97% (8.92%)
C/F margin (Industry Average)	- (-39.63%)
ROA (Industry Average)	2.37% (1.53%)
ROE (Industry Average)	2.79% (2.62%)
Growth	2009-12-31
Equity growth (Industry Average)	- (3.91%)
Sales growth (Industry Average)	- (-)
Net profit growth (Industry Average)	- (62.14%)
Operating C/F growth (Industry Average)	- (46.89%)
Stability	2009-12-31
Capital adequacy (Industry Average)	85.04% (57.57%)
Liquidity ratio (Industry Average)	424.84% (233.84%)
C/F ratio current liabilities (Industry Average)	- (31.87%)
Quick ratio (Industry Average)	246.83% (169.77%)
Turnover	2009-12-31
Receivables turnover (Industry Average)	105.82day (67.18day)
Inventory turnover (Industry Average)	28.53day (38.21day)
Payable turnover (Industry Average)	21.80day (34.24day)
Working capita turnover (Industry Average)	112.56day (71.15day)
Stock etc.	2009-12-31
Market Value growth (Industry Average)	- (24.19%)
Dividend Yield (Industry Average)	- (0.15%)
PER (Industry Average)	- (26.42%)
PBR (Industry Average)	- (1.54%)
PCFR (Industry Average)	- (4.97%)
PSR (Industry Average)	- (10.14%)

Financial Indicator Details: SSP

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-12-31
Profitability
Net profit margin	3.77%
C/F margin	6.43%
ROA	2.57%
ROE	3.11%
Recurring margin	8.87%
EBIT margin	6.09%
EBITDA margin	10.88%
NOPAT margin	3.65%
Sales SG rates	31.56%
Sales SG&A rates	61.54%
Sales R&D expenses rates	3.65%
Sales depreciation rates	4.79%
Capital expenditures net sales ratio	-2.93%
Indicator	2009-12-31
Growth
Growth rate of cash	-
Equity growth	-
Total assets growth	-
Sales growth	-
Net profit growth	-
Operating C/F growth	-
Recurring profit growth	-
EBIT growth	-
EBITDA growth	-
NOPAT growth	-
Operating expenses growth	-
Indicator	2009-12-31
Stability
Capital adequacy	82.73%
Liquidity ratio	398.85%
C/F ratio current liabilities	372.11%
Quick ratio	227.67%
Fixed ratio	29.84%
D/E ratio	0.85%
Loan to Value Ratio	0.71%
Business investment C/F ratio	-45.66%
Liabilities with interest growth	-
Indicator	2009-12-31
Turnover
Cash turnover	100.23day
Receivables turnover	98.62day
Inventory turnover	34.42day
Fixed assets turnover	132.09day
Total asset turnover	534.98day
Payable turnover	22.37day
Capital turnover	78.15day
Equity turnover	442.64day
Working capita turnover	110.67day
Indicator	2009-12-31
Balance sheet
Cash etc.	¥ 13 B
Accounts receivable-trade	¥ 12 B
Other Current Assets	¥ 32 B
Current Assets	¥ 45 B
Tangible Assets	¥ 17 B
Intangible Assets	¥ 1 B
Investment etc.	¥ 5 B
Total Assets	¥ 69 B
Current Liabilities	¥ 11 B
Fixed Liabilities	¥ 649 M
Liabilities with interest	¥ 495 M
Net Assets	¥ 57 B
Capital stock	¥ 10 B
Capital surplus etc.	¥ 47 B
Liabilities and net assets	¥ 69 B
Indicator	2009-12-31
Income statement
Sales	¥ 47 B
Cost of Sales	¥ 14 B
Gross profit	¥ 32 B
Other income	¥ 564 M
SG&A	¥ 29 B
Other expenses	¥ 2 B
Net income	¥ 1 B
Operating income	¥ 3 B
Ordinary Income	¥ 4 B
EBITDA	¥ 5 B
Income before income taxes	¥ 2 B
Depreciation	¥ 2 B
R&D expenses	¥ 1 B
Income taxes	¥ 1 B
Indicator	2009-12-31
Cash flow statement
Operating CF	¥ 3 B
Investment CF	¥ -3 B
Financial CF	¥ -11 B
Foreign Exchange Effects	¥ -21 M
Net Change in Cash	¥ -12 B
Free CF	¥ -626 M
Capital expenditures	¥ -1 B
Cash dividends paid	¥ -1 B
Repayment loans	¥ -139 M
Indicator	2009-12-31
Shareowners' equity
Issuance of new shares	-
Dividends from surplus	¥ -1 B
Net income	¥ 1 B
Purchase of treasury stock	¥ -29 M
Other Change in Stockholders Equity	-
Other Change in Net Assets	¥ -449 M
Net Change in Net Assets	¥ -424 M

Financial Indicator Details: SSP

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-12-31
Profitability
Net profit margin	3.97%
C/F margin	-
ROA	2.37%
ROE	2.79%
Recurring margin	9.72%
EBIT margin	6.63%
EBITDA margin	8.47%
NOPAT margin	3.97%
Sales SG rates	30.15%
Sales SG&A rates	62.49%
Sales R&D expenses rates	3.77%
Sales depreciation rates	1.83%
Capital expenditures net sales ratio	-
Indicator	2009-12-31
Growth
Growth rate of cash	-
Equity growth	-
Total assets growth	-
Sales growth	-
Net profit growth	-
Operating C/F growth	-
Recurring profit growth	-
EBIT growth	-
EBITDA growth	-
NOPAT growth	-
Operating expenses growth	-
Indicator	2009-12-31
Stability
Capital adequacy	85.04%
Liquidity ratio	424.84%
C/F ratio current liabilities	-
Quick ratio	246.83%
Fixed ratio	23.78%
D/E ratio	-
Loan to Value Ratio	-
Business investment C/F ratio	-
Liabilities with interest growth	-
Indicator	2009-12-31
Turnover
Cash turnover	111.07day
Receivables turnover	105.82day
Inventory turnover	28.53day
Fixed assets turnover	123.63day
Total asset turnover	611.24day
Payable turnover	21.80day
Capital turnover	89.49day
Equity turnover	519.82day
Working capita turnover	112.56day
Indicator	2009-12-31
Balance sheet
Cash etc.	¥ 12 B
Accounts receivable-trade	¥ 12 B
Other Current Assets	¥ 29 B
Current Assets	¥ 42 B
Tangible Assets	¥ 14 B
Intangible Assets	¥ 1 B
Investment etc.	¥ 11 B
Total Assets	¥ 69 B
Current Liabilities	¥ 9 B
Fixed Liabilities	¥ 403 M
Liabilities with interest	-
Net Assets	¥ 59 B
Capital stock	¥ 10 B
Capital surplus etc.	¥ 48 B
Liabilities and net assets	¥ 69 B
Indicator	2009-12-31
Income statement
Sales	¥ 41 B
Cost of Sales	¥ 12 B
Gross profit	¥ 28 B
Other income	¥ 551 M
SG&A	¥ 25 B
Other expenses	¥ 2 B
Net income	¥ 1 B
Operating income	¥ 3 B
Ordinary Income	¥ 4 B
EBITDA	¥ 3 B
Income before income taxes	¥ 2 B
Depreciation	¥ 763 M
R&D expenses	¥ 1 B
Income taxes	¥ 1 B
Indicator	2009-12-31
Cash flow statement
Operating CF	-
Investment CF	-
Financial CF	-
Foreign Exchange Effects	-
Net Change in Cash	-
Free CF	-
Capital expenditures	-
Cash dividends paid	-
Repayment loans	-
Indicator	2009-12-31
Shareowners' equity
Issuance of new shares	-
Dividends from surplus	¥ -1 B
Net income	¥ 1 B
Purchase of treasury stock	¥ -29 M
Other Change in Stockholders Equity	¥ 1 M
Other Change in Net Assets	¥ 45 M
Net Change in Net Assets	¥ -70 M

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: SSP (Annual )

Statement Type

Annual : SSP

First quarter : SSP

Second quarter : SSP

Third quarter : SSP

Analysis Menu

Outline : SSP

Statement : SSP

Rating : SSP

Indicator : SSP

Download : SSP

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo中央区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
SSP			Chemicals	12	Annual	-

Related Company

キッセイ薬品工業 (Sales ¥ 62 B)

ダイセル (Sales ¥ 358 B)

Nihon Parkrizing (Sales ¥ 89 B)

NIPPON KAYAKU (Sales ¥ 128 B)

NIPPON PAINT (Sales ¥ 233 B)

大正製薬ホールディングス (Sales ¥ 285 B)

Shin-Etsu Chemical (Sales ¥ 1.0 T)

エスケー化研 (Sales ¥ 82 B)

DAIICHI SANKYO (Sales ¥ 997 B)

TSUMURA & CO. (Sales ¥ 105 B)

Mitsubishi Tanabe Pharma (Sales ¥ 419 B)

NIHON NOHYAKU (Sales ¥ 47 B)

関西ペイント (Sales ¥ 294 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .